AAVrh.10-mediated genetic delivery of bevacizumab to the pleura to provide local anti-VEGF to suppress growth of metastatic lung tumors.
about
The pleural mesothelium in development and diseasePleural mesothelial cells in pleural and lung diseasesAAV2-mediated in vivo immune gene therapy of solid tumours.Targeted delivery of TrkB receptor to phrenic motoneurons enhances functional recovery of rhythmic phrenic activity after cervical spinal hemisection.Genetic modification of neurons to express bevacizumab for local anti-angiogenesis treatment of glioblastoma.An AAV vector-mediated gene delivery approach facilitates reconstitution of functional human CD8+ T cells in miceThe AAV vector toolkit: poised at the clinical crossroadsAAVrh.10-mediated expression of an anti-cocaine antibody mediates persistent passive immunization that suppresses cocaine-induced behavior.Anti-Epidermal Growth Factor Receptor Gene Therapy for GlioblastomaThe role of vascular endothelial growth factor in the pathogenesis, diagnosis and treatment of malignant pleural effusionAAV-mediated persistent bevacizumab therapy suppresses tumor growth of ovarian cancer.Translational advances in pleural malignancies.Gene-based therapy for alpha-1 antitrypsin deficiency.In situ production of therapeutic monoclonal antibodies.Adeno-associated virus (AAV) vectors in cancer gene therapy.State of play and clinical prospects of antibody gene transfer.Role of FGF10 on tumorigenesis by MS-K.Localized targeted antiangiogenic drug delivery for glioblastoma.
P2860
Q28391520-FE4C989D-4EB1-4473-B200-B710D4D2F66AQ28396403-BF41042A-2CB2-4029-8CD0-05B0A93D4558Q34468330-E66CD3D2-9B0B-4377-898B-09D136353568Q34749792-327F5B61-42F3-47C7-97E8-8A070B508D1FQ34943946-B8971E74-CE1E-4E9C-AD27-F3FB991C9C5BQ35091621-A2F0DCBF-3F4B-4068-AB5B-40357C0AD031Q35876224-B7F80DDB-C3B3-478A-B9C9-4E880F979076Q35988700-C0E15EC7-A70A-4757-9ABE-25B4341B4721Q36155208-C5C3AE7C-98A0-4E8F-87A7-F294102E11B2Q36907325-1E4F836B-7991-4FFF-8D0B-E183102EB49DQ37374843-2687F36C-BA9D-498A-8653-139C124F3474Q37806309-F4B8E2F0-DE36-41F9-855E-35E42D36ECA7Q38092873-C14A7A3E-DDA5-4E37-AC1B-6BDB544A2020Q38314210-11D2392A-A33C-4436-B50C-09934B322A0BQ38706321-6E2F5ED0-7865-4636-92F3-6A30B716714EQ38737706-C01E3D2E-3278-40E5-8354-38258D3EE44CQ39045204-B424B6C7-5F2F-4D5B-BF97-DF97771FDF0EQ47736401-FB0BDB5E-0DCA-4581-9AF8-DED6F3F545E6
P2860
AAVrh.10-mediated genetic delivery of bevacizumab to the pleura to provide local anti-VEGF to suppress growth of metastatic lung tumors.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
AAVrh.10-mediated genetic deli ...... wth of metastatic lung tumors.
@ast
AAVrh.10-mediated genetic deli ...... wth of metastatic lung tumors.
@en
AAVrh.10-mediated genetic deli ...... wth of metastatic lung tumors.
@nl
type
label
AAVrh.10-mediated genetic deli ...... wth of metastatic lung tumors.
@ast
AAVrh.10-mediated genetic deli ...... wth of metastatic lung tumors.
@en
AAVrh.10-mediated genetic deli ...... wth of metastatic lung tumors.
@nl
prefLabel
AAVrh.10-mediated genetic deli ...... wth of metastatic lung tumors.
@ast
AAVrh.10-mediated genetic deli ...... wth of metastatic lung tumors.
@en
AAVrh.10-mediated genetic deli ...... wth of metastatic lung tumors.
@nl
P2093
P2860
P356
P1433
P1476
AAVrh.10-mediated genetic deli ...... wth of metastatic lung tumors.
@en
P2093
M Watanabe
R G Crystal
P2860
P2888
P304
P356
10.1038/GT.2010.87
P577
2010-07-01T00:00:00Z